216 related articles for article (PubMed ID: 34940070)
21. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
[TBL] [Abstract][Full Text] [Related]
22. Splenic lymphoma with villous lymphocytes with CD5+, CD11c+ B-cell phenotype.
Miyawaki S; Machii T; Hirabayashi H; Sakura T; Shiozaki H; Yashiro K; Murakami H; Tsuchiya J; Kashiwabara K; Kitani T
Intern Med; 1993 Jun; 32(6):472-5. PubMed ID: 7694693
[TBL] [Abstract][Full Text] [Related]
23. [Tumors of lymphoid and hematopoietic tissue of spleen: a clinicopathologic analysis of 53 cases].
Chen DB; Shen DH; Zhang H; Wang Y; Song QJ; Yang SM; Fang XZ
Zhonghua Bing Li Xue Za Zhi; 2017 Nov; 46(11):775-781. PubMed ID: 29136691
[No Abstract] [Full Text] [Related]
24. Clinicopathological analysis of splenic red pulp low-grade B-cell lymphoma.
Suzuki T; Miyoshi H; Shimono J; Kawamoto K; Arakawa F; Furuta T; Yamada K; Yanagida E; Takeuchi M; Seto M; Sone H; Takizawa J; Ohshima K
Pathol Int; 2020 May; 70(5):280-286. PubMed ID: 32052529
[TBL] [Abstract][Full Text] [Related]
25. The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes.
Matutes E; Morilla R; Owusu-Ankomah K; Houliham A; Meeus P; Catovsky D
Leuk Lymphoma; 1994; 14 Suppl 1():57-61. PubMed ID: 7820054
[TBL] [Abstract][Full Text] [Related]
26. Immunophenotypic Analysis of Hairy Cell Leukemia (HCL) and Hairy Cell Leukemia-like (HCL-like) Disorders.
Maitre E; Cornet E; Salaün V; Kerneves P; Chèze S; Repesse Y; Damaj G; Troussard X
Cancers (Basel); 2022 Feb; 14(4):. PubMed ID: 35205796
[TBL] [Abstract][Full Text] [Related]
27. The diagnostic value of CD123 in B-cell disorders with hairy or villous lymphocytes.
Del Giudice I; Matutes E; Morilla R; Morilla A; Owusu-Ankomah K; Rafiq F; A'Hern R; Delgado J; Bazerbashi MB; Catovsky D
Haematologica; 2004 Mar; 89(3):303-8. PubMed ID: 15020268
[TBL] [Abstract][Full Text] [Related]
28. CD5-Negative, CD10-Negative Low-Grade B-Cell Lymphoproliferative Disorders of the Spleen.
Schmieg JJ; Muir JM; Aguilera NS; Auerbach A
Curr Oncol; 2021 Dec; 28(6):5124-5147. PubMed ID: 34940069
[TBL] [Abstract][Full Text] [Related]
29. [Clinicopathologic study of splenic marginal zone B-cell lymphoma].
Zhang YN; Zheng YY; Zhou XG; Zhang SH; Jin Y; Xie JL; Chen SY; Shi Y; Wu LH
Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):243-7. PubMed ID: 19575895
[TBL] [Abstract][Full Text] [Related]
30. Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma.
Verney A; Traverse-Glehen A; Callet-Bauchu E; Jallades L; Magaud JP; Salles G; Genestier L; Baseggio L
Oncotarget; 2018 May; 9(34):23589-23598. PubMed ID: 29805758
[TBL] [Abstract][Full Text] [Related]
31. Splenic marginal zone lymphoma.
Dogan A; Isaacson PG
Semin Diagn Pathol; 2003 May; 20(2):121-7. PubMed ID: 12945935
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow histopathology in the diagnostic evaluation of splenic marginal-zone and splenic diffuse red pulp small B-cell lymphoma: a reliable substitute for spleen histopathology?
Ponzoni M; Kanellis G; Pouliou E; Baliakas P; Scarfò L; Ferreri AJ; Doglioni C; Bikos V; Dagklis A; Anagnostopoulos A; Ghia P; Stamatopoulos K; Papadaki T
Am J Surg Pathol; 2012 Nov; 36(11):1609-18. PubMed ID: 23073320
[TBL] [Abstract][Full Text] [Related]
33. The role of splenectomy in management of splenic B-cell lymphomas.
Archibald WJ; Baran AM; Williams AM; Salloum RM; Richard Burack W; Evans AG; Syposs CR; Zent CS
Leuk Res; 2023 May; 128():107053. PubMed ID: 36906942
[TBL] [Abstract][Full Text] [Related]
34. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow and splenic histology in hairy cell leukaemia.
Wotherspoon A; Attygalle A; Mendes LS
Best Pract Res Clin Haematol; 2015 Dec; 28(4):200-7. PubMed ID: 26614898
[TBL] [Abstract][Full Text] [Related]
36. Distinguishing hairy cell leukemia variant from hairy cell leukemia: development and validation of diagnostic criteria.
Shao H; Calvo KR; Grönborg M; Tembhare PR; Kreitman RJ; Stetler-Stevenson M; Yuan CM
Leuk Res; 2013 Apr; 37(4):401-409. PubMed ID: 23347903
[TBL] [Abstract][Full Text] [Related]
37. First reported case of splenic diffuse red pulp small B-cell lymphoma with novel mutations in CXCR4 and TRAF3 genes.
Zheng S; Lin L; Jin J; Liu F; Wei J; Feng Y; Zhang Y; Luo H; Qin J; Feng W
Int J Hematol; 2023 Sep; 118(3):394-399. PubMed ID: 36935465
[TBL] [Abstract][Full Text] [Related]
38. Splenic marginal zone lymphoma.
Franco V; Florena AM; Iannitto E
Blood; 2003 Apr; 101(7):2464-72. PubMed ID: 12446449
[TBL] [Abstract][Full Text] [Related]
39. Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma.
Catovsky D; Matutes E
Semin Hematol; 1999 Apr; 36(2):148-54. PubMed ID: 10319383
[TBL] [Abstract][Full Text] [Related]
40. Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?
Traverse-Glehen A; Baseggio L; Bauchu EC; Morel D; Gazzo S; Ffrench M; Verney A; Rolland D; Thieblemont C; Magaud JP; Salles G; Coiffier B; Berger F; Felman P
Blood; 2008 Feb; 111(4):2253-60. PubMed ID: 18042795
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
